I started Oncology Discovery as a vehicle to share my thoughts related to emerging therapeutic technologies aimed at curing cancer.
My day job involves Biopharmaceutical Business Development Competitive Intelligence. Previously, I completed a Postdoc at AstraZeneca Pharmaceuticals within the Oncology iMED. While at AZ I worked on BET protein function in cancer. I was involved in defining the pharmacology of a novel BET (i.e. BRD4) inhibitor, and delineated BET dependencies in solid tumors.
Throughout my career I’ve had the privilege of working with many talented colleagues, collaborators, and mentors. As a result of these relationships, I’ve been fortunate to have some of my work published in peer-reviewed journals, including Cancer Cell, Blood, Leukemia, British Journal of Cancer, and Experimental Hematology. You can find my published work on Pubmed and Google Scholar.
I received my PhD in Cancer and Cell Biology from The University of Cincinnati, and completed my thesis research at Cincinnati Children’s Hospital within the Cancer and Blood Diseases Institute, where I worked on IRAK family kinases as potential therapeutic targets in Myelodysplastic Syndrome and Acute Myeloid Leukemia.